Appt. of a Contract Manufacturing Organisation for Production of DST-F to GMP

Published facts

What the notice says

Buyer

ANIMAL AND PLANT HEALTH AGENCY

Published status

complete

Latest release reference

054474-2026

CPV codes

Common Procurement Vocabulary (CPV) codes: 33600000

Published tags

award, contract

Latest record Bidwake loaded from this source

27 Aug 2026

A Contract Manufacturing Organisation (CMO) certified to EU Good Manufacturing Practice (GMP) standards is required to work in partnership with the Authority to achieve UK Marketing Authorisation (MA) and, thereafter, for scaled up production of the DST-F product, a diagnostic skin test to Detect Infected among Vaccinated Animals (DIVA). This will involve the technology transfer of the research grade product from the current non-GMP provider and the production of consistency batches.

Open the official Find a Tender notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

1. Planning notice observed

   2 Jun 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   029195-2025

   Published tags

   planning

2. Planning notice observed

   6 Jun 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   030560-2025

   Published tags

   planning

3. Planning notice observed

   5 Sept 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   054409-2025

   Published tags

   planning

4. Planning record updated

   5 Sept 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

Awards and suppliers

Published award and contract facts

• Appt. of a Contract Manufacturing Organisation for Production of DST-F to GMP

  Buyer: ANIMAL AND PLANT HEALTH AGENCYSupplier: Thermo Fisher Scientific Prionic Lelystad B.V.

  End date in notice

  7 Jun 2033Date from the linked contract

  Value shown in notice

  £27,677,784Value from the linked contract

  Official source

  Open the official Find a Tender notice for Appt. of a Contract Manufacturing Organisation for Production of DST-F to GMP

  About this figure

  • This figure comes from the linked contract record. Overall totals continue to use the separately published award value.

  View record references

  Source

  Find a Tender

  Award or lot reference

  2

Related evidence

Published terms and linked processes

• Renewal information is statedLot 1Repeated in 2 notices; the most recent statement is shown.Published 6 Jun 2025.Open supporting notice 030560-2025
• Options are statedLot 1

  The Contracting Authority may, at its sole discretion, exercise one or more of the following options during the term of the Contract: - Grant a commercial licensing agreement to the successful Supplier for the manufacture and supply of DST-F to Rest of World (RoW) markets, subject to separate agreement and regulatory approvals. - Expand the scope of services to include support for additional Marketing Authorisation applications outside Great Britain. - Increase the volume of DST-F doses required, subject to policy changes and budget availability. These options are provided for in the original procurement and shall be exercised only where they do not substantially alter the nature of the Contract. The Supplier shall be notified in writing of the Authority’s intention to exercise any option, and the parties shall agree any contract variations

  Repeated in 3 notices; the most recent statement is shown.Published 10 Nov 2025.Open supporting notice 072500-2025
• Renewal information is statedLot 1

  The Contracting Authority reserves the right to extend the Contract by up to twenty-four (24) months, in increments of twelve (12) months, subject to satisfactory performance and continued operational need. Any extension shall be exercised by giving the Supplier no less than six (6) months’ written notice prior to the expiry of the initial term. All terms and conditions shall remain unchanged during the extension period unless otherwise agreed in writing.

  Repeated in 3 notices; the most recent statement is shown.Published 10 Nov 2025.Open supporting notice 072500-2025
• Options are statedLot 1

  The Contracting Authority may, at its sole discretion, exercise one or more of the following options during the term of the Contract: - Grant a commercial licensing agreement to the successful Supplier for the manufacture and supply of DST-F to Rest of World (RoW) markets, subject to separate agreement and regulatory approvals. - Expand the scope of services to include support for additional Marketing Authorisation applications outside Great Britain. - Increase the volume of DST-F doses required, subject to policy changes and budget availability. These options are provided for in the original procurement and shall be exercised only where they do not substantially alter the nature of the Contract. The Supplier shall be notified in writing of the Authority's intention to exercise any option, and the parties shall agree any contract variations